🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

GREAT publication by the SotilloLab Really nice collaborative effort from The Harris Lab, Papavasiliou & Stebbins Labs, Ben-David Lab and super cool new findings on APOBEC3B!

acir.org/weekly-digests… Please see some more information and comments on our newly published Nature Cancer paper together with Miki de Palma.

Great collaborative work with Maja Fink and Michael Boutros! Happy to be part of this! Learned a lot - more to come :-).

GREAT to see our collabroative effort as the cover of the current issue of Nature Cancer - what an instructive ride! Thank you to the whole team - First of all to Mikki and his team but also to all other collaborators!! Learned so much - more to come...

Great talk tomorrow at the M3 by Prof. Dr. Burkhard Ludewig - join us! x.com/MedTuebingen/s…

Looking forward to a great talk and discussion session!

A great team of people at the DKFZ, University Clinics Tübingen, University Tübingen, University Heidelberg, Monash University and King´s colleague helped us on the way supported us - a team effort - with clincial implications - that we follow up. Thank you to all collaborators.

‼️New Article‼️ Intermittent fasting protects against liver inflammation and liver cancer. Check out the new paper published by the THRIVE member Mathias Heikenwälder from DKFZ and Universität Tübingen Cell Metabolism Cell 👇👇👇 sciencedirect.com/science/articl…

GREAT to be supported by THRIVE Liver Cancer EU Project and the fantastic groups thereof in this project.

Great brainstorming at the first #THRIVE working meeting in Tavertet! Two wonderful days filled with new ideas for putting our plans into action, achieving our goals and advancing collaborative projects within the consortium. #LiverTwitter #CancerResearch #EU

Mathias Heikenwälder from DKFZ presented research seeking to increase therapeutic options for liver cancer through deciphering the hepatic inflammatory environment in tissue damage and cancer development #BICC2024

Great collaborative work between many groups - with a quite surprising result: sciencedirect.com/science/articl… - it has been a real pleasure and a real journey in which we learned a lot.

The work was led by Suchira Gallage, the Metabolic Signalling Group and the Senescence Group at MRC Laboratory of Medical Sciences (LMS) in collaboration with Mathias Heikenwälder #AgingResearch #Longevity #NatureAging

Great collaboration with the laboratory of Tom Luedde and many others. Once again very inspiring and fruitful.

Happy that this collaborative effort is out. Thanks to the laboratories of Ulrike Protzer, Massimo Levrero, Heiner Wedmeyer, Roland Rad, Kristian Unger, and many others. A true long-term colaboration - led by Marc Ringelhan and Svenja Schüle doi.org/10.1016/j.jhep…

We show: -HBV1.3 transgenic mice develop HCC in the absence of inflammation. - HBVxfs mice, expressing all HBV proteins but a truncated HBx, display significantly reduced HCC incidence. - Hepatocyte-specific STAT3-knockout abrogates HCC development.

Universität Düsseldorf: Leberkrebs: Die Fitness von Tumorzellen als Angriffspunkt für neue Therapien medizin.hhu.de/news-detailinf…

What a great collaboration - hard work and exciting results. More to come ! Danke Moritz Mall, team and all collaborators.

The next appointment of our i2 DKFZ seminar series is on Thursday, October 31st, at 4 pm. We'll hear two Data & Technique talks by Ilka Wahl, postdoc in Hedda Wardemann’s lab, and Kam Shing, PhD student in Mathias Heikenwälder’s lab. Join us for a lively discussion! More info 👇

#CellPlasticity—the ability of cells to change their identity—is vital for tissue growth and repair. But when it goes unchecked, it can fuel #cancer. Our latest study examines how to block #LiverCancer by actively suppressing plasticity. nature.com/articles/s4158… #CancerBiology